viral vector manufacturing bottlenecks
3 Surprising Reasons Your Scale-Up Strategy Is Broken
3 Surprising Reasons Your Scale-Up Strategy Is Broken In 2022, my team faced a 7-month delay because we waited for a stable cell line before confirming transfection feasibility. Relying on default stable-line routes, ignoring upstream bottlenecks, and skipping transient de-risking leaves your scale-up plan fragile. Why the Rush to Stable